Skip to main content
Clinical Trials/NCT02692534
NCT02692534CompletedNot Applicable

Cocaine Use and General Anesthesia: A Prospective Study of Cardiovascular and Anesthetic Effects

University of Texas Southwestern Medical Center1 site in 1 country300 target enrollmentStarted: April 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
300
Locations
1
Primary Endpoint
Adverse intraoperative cardiovascular events

Study Overview

Brief Summary

In this prospective study, investigators plan to evaluate the outcome of general anesthesia in the context of patients with a positive cocaine urine test. Patients with a positive urine cocaine test who do not appear acutely toxic and have normal vital signs may not have an increased rate of perioperative complications during elective surgery compared to similar patients with negative urine cocaine screening tests. Patients who are chronic cocaine users may have a higher anesthetic requirement.

Detailed Description

Patients with a history of cocaine abuse who are scheduled to undergo surgery at Parkland Hospital will be asked to provide a urine sample for a screening toxicology test on the day of surgery. Patients will also be asked to fill out a questionnaire with questions pertaining to their drug use history. The remaining aspects of perioperative care, including the general anesthetic technique, will be standardized for all patients and will not differ from the standard of care. The anesthesia faculty, resident, or CRNA will identify patients and obtain consent and ask the patient to fill out the questionnaire. This prospective study is intended to enroll about 300 cocaine positive and negative patients over a 2 year period.

Blood samples will be collected for analysis of cardiac troponin T (cTnT) pre- and postoperatively.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18-70 years old
  • ASA physical status classification 1 to 3
  • Personal history of cocaine abuse
  • Scheduled for a non-emergent operation that requires general anesthesia
  • Vital signs within generally accepted ranges for normal [HR 60-100, RR 12-20, SpO2 > 96% on room air, BP 90-140/60-90 unless a diagnosis of hypertension is present, T 36-38 degrees)
  • Willing and able to consent in English or Spanish

Exclusion Criteria

  • Age less than 18 or older than 70
  • Unable to give informed consent for participation in the study
  • Patient refusal
  • Monitored anesthesia care (MAC) or regional anesthesia planned
  • Pregnant or lactating
  • Emergent surgery
  • Acute cocaine intoxication based on clinical symptomatology (hypertension, tachycardia, agitation, delirium, hyperthermia)
  • History of cardiac disease including coronary artery disease (CAD) and cardiac dysrhythmia
  • History of stroke
  • History of seizure disorder
  • Prison patient

Outcomes

Primary Outcomes

Adverse intraoperative cardiovascular events

Time Frame: Intraoperatively, from the time of "anesthesia start" until "anesthesia end," generally 2-4 hours

Proportion of total anesthesia duration that mean arterial pressure (MAP) \<65 or \>105

Adverse postoperative cardiovascular events

Time Frame: Postoperatively up to 24 hours

Increase in the postoperative troponin value compared to the patient¹s baseline preoperative troponin value

Secondary Outcomes

  • The percentage of volatile anesthetic used(Intraoperatively, from the time of "anesthesia start" until "anesthesia end," generally 2-4 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tiffany B Moon

Associate Professor

University of Texas Southwestern Medical Center

Study Sites (1)

Loading locations...

Similar Trials